Related Experiment Video
Updated: Jan 6, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and
Paul Jarrett1, Fiona M Coyer2, Debbie Long3
1School of Nursing and Centre for Healthcare Transformation, Queensland University of Technology, Brisbane, Qld, Australia; Nursing and Midwifery Research Centre, Royal Brisbane & Women's Hospital, Brisbane, Qld, Australia.
Background:
Residual drug error (RDE) is defined as the unintentional retention of medication in intravenous delivery systems after administration. This is a growing concern in the intensive care unit (ICU), particularly in regard to antibiotics.
Aims/Objectives:
The aim of this study was to explore clinicians' awareness of RDE, its perceived causes, and potential strategies to reduce its occurrence.
Methods:
A qualitative approach using focus groups was conducted with ICU nurses, examining their awareness of RDE, contributing factors, and ideas for prevention. Thematic analysis was used to identify key themes and subthemes from the data.
Results:
Twenty-seven participants participated in four focus groups over four mandatory training days. Clinicians' experiences with RDEs in the ICU were categorised into three main themes: (i) Awareness and perception of RDEs; (ii) Potential causes of RDE, including knowledge gaps, workload pressures, and inconsistent double-checking and documentation practices; and (iii) Proposed solutions to minimise RDEs including enhanced education, standardised protocols, and improved documentation.
Conclusions:
ICU nurses demonstrated limited prior awareness of RDE, with participants identifying multiple contributing factors including personal practice variability, drug characteristics, workload pressures, and reconstitution technique. Proposed solutions centred on targeted education, consistent double-checking and signing procedures, and concise, accessible checklists. These findings can inform the development of practical, context-appropriate strategies to improve medication accuracy and patient safety in the ICU.
Insights
Intensive care unit nurses had low awareness of residual drug error (RDE), a medication retention issue. Solutions include better education, standardized protocols, and improved documentation to enhance patient safety.
Area of Science:
- Medical Safety
- Pharmacology
- Nursing Practice
Background:
- Residual drug error (RDE) is the unintentional retention of medication in intravenous systems.
- RDE is a growing concern in intensive care units (ICUs), especially with antibiotic administration.
Purpose of the Study:
- To explore ICU clinicians' awareness of RDE.
- To identify perceived causes of RDE.
- To determine potential strategies for RDE reduction.
Main Methods:
- Qualitative study utilizing focus groups with ICU nurses.
- Thematic analysis of focus group data to identify key themes.
- Explored awareness, contributing factors, and prevention ideas for RDE.
Main Results:
- Twenty-seven ICU nurses participated in four focus groups.
- Identified three main themes: awareness/perception of RDE, causes (knowledge gaps, workload, inconsistent practices), and solutions (education, protocols, documentation).
- Nurses reported limited prior awareness of RDE.
Conclusions:
- ICU nurses have limited awareness of RDE and identified various contributing factors.
- Proposed solutions include targeted education, standardized double-checking, and improved documentation.
- Findings can guide practical strategies to improve medication accuracy and patient safety in ICUs.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antibiotic Selection
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

